###begin article-title 0
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPARG</italic>
###xml 7 13 7 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KCNJ11</italic>
###xml 15 21 15 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDKAL1</italic>
###xml 23 36 23 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDKN2A-CDKN2B</italic>
###xml 38 52 38 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IDE-KIF11-HHEX</italic>
###xml 54 61 54 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IGF2BP2</italic>
###xml 66 73 66 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC30A8</italic>
PPARG, KCNJ11, CDKAL1, CDKN2A-CDKN2B, IDE-KIF11-HHEX, IGF2BP2 and SLC30A8 Are Associated with Type 2 Diabetes in a Chinese Population
###end article-title 0
###begin p 1
Conceived and designed the experiments: CH YB KX WJ. Performed the experiments: CH RZ CW XM JL WQ. Analyzed the data: CH XH. Wrote the paper: CH JW CW WJ.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
Recent advance in genetic studies added the confirmed susceptible loci for type 2 diabetes to eighteen. In this study, we attempt to analyze the independent and joint effect of variants from these loci on type 2 diabetes and clinical phenotypes related to glucose metabolism.
###end p 3
###begin title 4
Methods/Principal Findings
###end title 4
###begin p 5
###xml 701 706 701 706 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPARG</italic>
###xml 708 714 708 714 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KCNJ11</italic>
###xml 716 722 716 722 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDKAL1</italic>
###xml 724 737 724 737 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDKN2A-CDKN2B</italic>
###xml 739 753 739 753 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IDE-KIF11-HHEX</italic>
###xml 755 762 755 762 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IGF2BP2</italic>
###xml 767 774 767 774 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC30A8</italic>
###xml 850 851 850 851 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 952 968 952 968 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WFS1, FTO, JAZF1</italic>
###xml 970 981 970 981 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TSPAN8-LGR5</italic>
###xml 983 988 983 988 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">THADA</italic>
###xml 990 997 990 997 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ADAMTS9</italic>
###xml 999 1012 999 1012 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NOTCH2-ADAM30</italic>
###xml 1106 1111 1106 1111 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">THADA</italic>
###xml 1196 1197 1196 1197 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1218 1219 1218 1219 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1479 1480 1479 1480 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1408 1416 <span type="species:ncbi:9606">patients</span>
Twenty-one single nucleotide polymorphisms (SNPs) from fourteen loci were successfully genotyped in 1,849 subjects with type 2 diabetes and 1,785 subjects with normal glucose regulation. We analyzed the allele and genotype distribution between the cases and controls of these SNPs as well as the joint effects of the susceptible loci on type 2 diabetes risk. The associations between SNPs and type 2 diabetes were examined by logistic regression. The associations between SNPs and quantitative traits were examined by linear regression. The discriminative accuracy of the prediction models was assessed by area under the receiver operating characteristic curves. We confirmed the effects of SNPs from PPARG, KCNJ11, CDKAL1, CDKN2A-CDKN2B, IDE-KIF11-HHEX, IGF2BP2 and SLC30A8 on risk for type 2 diabetes, with odds ratios ranging from 1.114 to 1.406 (P value range from 0.0335 to 1.37E-12). But no significant association was detected between SNPs from WFS1, FTO, JAZF1, TSPAN8-LGR5, THADA, ADAMTS9, NOTCH2-ADAM30 and type 2 diabetes. Analyses on the quantitative traits in the control subjects showed that THADA SNP rs7578597 was association with 2-h insulin during oral glucose tolerance tests (P = 0.0005, empirical P = 0.0090). The joint effect analysis of SNPs from eleven loci showed the individual carrying more risk alleles had a significantly higher risk for type 2 diabetes. And the type 2 diabetes patients with more risk allele tended to have earlier diagnostic ages (P = 0.0006).
###end p 5
###begin title 6
Conclusions/Significance
###end title 6
###begin p 7
###xml 52 57 52 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPARG</italic>
###xml 59 65 59 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KCNJ11</italic>
###xml 67 73 67 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDKAL1</italic>
###xml 75 88 75 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDKN2A-CDKN2B</italic>
###xml 90 104 90 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IDE-KIF11-HHEX</italic>
###xml 106 113 106 113 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IGF2BP2</italic>
###xml 118 125 118 125 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC30A8</italic>
The current study confirmed the association between PPARG, KCNJ11, CDKAL1, CDKN2A-CDKN2B, IDE-KIF11-HHEX, IGF2BP2 and SLC30A8 and type 2 diabetes. These type 2 diabetes risk loci contributed to the disease additively.
###end p 7
###begin title 8
Introduction
###end title 8
###begin p 9
###xml 340 343 340 343 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007643-Gloyn1">[1]</xref>
###xml 588 593 588 593 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPARG</italic>
###xml 595 601 595 601 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KCNJ11</italic>
###xml 606 612 606 612 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
###xml 674 680 674 680 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDKAL1</italic>
###xml 682 695 682 695 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDKN2A-CDKN2B</italic>
###xml 697 711 697 711 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IDE-KIF11-HHEX</italic>
###xml 713 720 713 720 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IGF2BP2</italic>
###xml 722 729 722 729 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC30A8</italic>
###xml 734 737 734 737 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FTO</italic>
###xml 737 740 737 740 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007643-Zeggini1">[2]</xref>
###xml 742 745 742 745 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007643-Saxena1">[3]</xref>
###xml 747 750 747 750 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007643-Scott1">[4]</xref>
###xml 752 755 752 755 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007643-Sladek1">[5]</xref>
###xml 828 833 828 833 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">JAZF1</italic>
###xml 835 846 835 846 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TSPAN8-LGR5</italic>
###xml 848 853 848 853 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">THADA</italic>
###xml 855 862 855 862 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ADAMTS9</italic>
###xml 864 877 864 877 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NOTCH2-ADAM30</italic>
###xml 882 895 882 895 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDC123-CAMK1D</italic>
###xml 967 970 967 970 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007643-Zeggini2">[6]</xref>
###xml 1044 1049 1044 1049 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KCNQ1</italic>
###xml 1098 1101 1098 1101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007643-Unoki1">[7]</xref>
###xml 1103 1106 1103 1106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007643-Yasuda1">[8]</xref>
###xml 1161 1165 1161 1165 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF2</italic>
###xml 1170 1174 1170 1174 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WFS1</italic>
###xml 1174 1177 1174 1177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007643-Winckler1">[9]</xref>
###xml 1179 1183 1179 1183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007643-Wasson1">[10]</xref>
Type 2 diabetes is a complex disease characterized by elevated blood glucose, caused mainly by impairment in both insulin action and beta cell function. Although the sharp increase in prevalence of type 2 diabetes worldwide is attributed to changes in individual environmental exposure pattern, genetic factors do predispose to the disease [1]. Recently, spectacular advance was made in identifying susceptible genes involved in type 2 diabetes through genome-wide association studies (GWAS). Several groups reported independent GWAS in Caucasians, which not only confirmed the effect of PPARG, KCNJ11 and TCF7L2, but also identified six novel susceptibility loci including CDKAL1, CDKN2A-CDKN2B, IDE-KIF11-HHEX, IGF2BP2, SLC30A8 and FTO[2], [3], [4], [5]. And meta-analysis on three Caucasian GWAS yielded six additional loci (JAZF1, TSPAN8-LGR5, THADA, ADAMTS9, NOTCH2-ADAM30 and CDC123-CAMK1D) associated with type 2 diabetes at genome-wide statistic significance [6]. Moreover, the first two independent GWAS in East Asian population added KCNQ1 to the list of type 2 diabetes susceptible gene [7], [8]. In addition with two well replicated candidate genes TCF2 and WFS1[9], [10], eighteen susceptible loci of type 2 diabetes were well recognized to date.
###end p 9
###begin p 10
###xml 131 137 131 137 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDKAL1</italic>
###xml 139 152 139 152 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDKN2A-CDKN2B</italic>
###xml 154 166 154 166 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IDE-KIF-HHEX</italic>
###xml 168 175 168 175 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IGF2BP2</italic>
###xml 177 184 177 184 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC30A8</italic>
###xml 186 189 186 189 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FTO</italic>
###xml 194 200 194 200 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
###xml 200 204 200 204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007643-Ng1">[11]</xref>
###xml 206 210 206 210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007643-Wu1">[12]</xref>
###xml 212 216 212 216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007643-Horikawa1">[13]</xref>
###xml 345 349 345 349 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF2</italic>
###xml 354 359 354 359 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KCNQ1</italic>
###xml 426 430 426 430 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007643-Hu1">[14]</xref>
###xml 432 436 432 436 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007643-Wang1">[15]</xref>
Several researches tried to replicate some of these loci in the Asian populations and confirmed the effects of genetic variants in CDKAL1, CDKN2A-CDKN2B, IDE-KIF-HHEX, IGF2BP2, SLC30A8, FTO and TCF7L2[11], [12], [13]. However, limited study analyzed all these susceptible loci in the Asian population. Previously, we reported the association of TCF2 and KCNQ1 genetic variants with type 2 diabetes in our case-control samples [14], [15], thus we tested the effects of genetic variants from the other sixteen loci as well as the joint effect of variants from all these eighteen loci on type 2 diabetes and related clinical traits in this study.
###end p 10
###begin title 11
Methods
###end title 11
###begin title 12
Ethnic statement
###end title 12
###begin p 13
###xml 108 114 <span type="species:ncbi:9606">People</span>
###xml 243 254 <span type="species:ncbi:9606">participant</span>
This study was approved by the institutional review board of Shanghai Jiao Tong University Affiliated Sixth People's Hospital was in accordance with the principle of the Helsinki Declaration II. Written informed consent was obtained from each participant.
###end p 13
###begin title 14
Study population
###end title 14
###begin p 15
###xml 432 436 428 432 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007643-Alberti1">[16]</xref>
###xml 580 588 576 584 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Leu(UUR)</sup>
###xml 720 724 716 720 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007643-Jia1">[17]</xref>
###xml 1259 1266 1255 1262 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007643-t001">Table 1</xref>
###xml 63 71 <span type="species:ncbi:9606">patients</span>
###xml 155 163 <span type="species:ncbi:9606">patients</span>
###xml 259 265 <span type="species:ncbi:9606">People</span>
###xml 680 692 <span type="species:ncbi:9606">participants</span>
###xml 1005 1016 <span type="species:ncbi:9606">participant</span>
A total of 3,634 individuals, comprising 1,849 type 2 diabetes patients and 1,785 normal controls, were included in the present study. The type 2 diabetes patients were recruited from the inpatient department of Shanghai Jiao Tong University Affiliated Sixth People's Hospital. Diabetes was defined according to 1999 World Health Organization criteria (fasting plasma glucose >/=7.0 mmol/l and/or 2-h plasma glucose >/=11.1 mmol/l) [16]. Individuals with glutamic acid decarboxylase and/or protein tyrosine phosphatase IA-2 antibodies positive were excluded and mitochondria tRNA Leu(UUR) nt3243 A-to-G mutation carriers were excluded as well. The controls were selected from the participants of Shanghai Diabetes Study [17]. In the present study, the inclusion criteria for the control subjects were: 1) over 40 years old; 2) with normal glucose regulation confirmed by a standard 75 g oral glucose tolerance test (OGTT); 3) with negative family history of diabetes by a standard questionnaire. For each participant, glucose tolerance status was confirmed according to 1999 World Health Organization criteria (fasting plasma glucose <6.1 mmol/l and 2-h postprandial plasma glucose <7.8 mmol/l). The clinical characteristics of the study groups were shown in Table 1.
###end p 15
###begin title 16
Clinical characteristics of study population.
###end title 16
###begin p 17
Data are shown as mean+/-SD or median (interquartile range).
###end p 17
###begin p 18
At the level of significance of 0.05, our case-control samples had over 80% power to detect a minimum odds ratio (OR) of 1.15 for a single nucleotide polymorphism (SNP) with minor allele frequency (MAF) over 0.2, a minimum OR of 1.24 for a SNP with MAF of 0.1 and a minimum OR of 1.33 for a SNP with MAF of 0.05.
###end p 18
###begin title 19
Biochemical and anthropometric measures
###end title 19
###begin p 20
###xml 628 632 625 629 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007643-Matthews1">[18]</xref>
###xml 4 16 <span type="species:ncbi:9606">participants</span>
All participants underwent a detailed clinical investigation. Anthropometric variables including height, weight, waist and hip circumferences were measured. For the controls, blood samples were obtained at 0 and 120 min during standard 75 g OGTTs. Plasma glucose concentrations were measured by the glucose oxidase-peroxidase method using commercial kits (Shanghai Biological Products Institution, Shanghai, China). Serum insulin levels were measured by radioimmunoassay (Linco Research, St Charles, MO, USA). Homeostasis model assessment (HOMA) was used to estimate insulin resistance (HOMA-IR) and beta-cell function (HOMA-B) [18].
###end p 20
###begin title 21
SNP selection and genotyping
###end title 21
###begin p 22
###xml 152 157 152 157 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPARG</italic>
###xml 171 177 171 177 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KCNJ11</italic>
###xml 188 192 188 192 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WFS1</italic>
###xml 207 213 207 213 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
###xml 227 233 227 233 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDKAL1</italic>
###xml 295 308 295 308 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDKN2A-CDKN2B</italic>
###xml 336 350 336 350 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IDE-KIF11-HHEX</italic>
###xml 391 398 391 398 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IGF2BP2</italic>
###xml 412 419 412 419 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC30A8</italic>
###xml 434 437 434 437 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FTO</italic>
###xml 451 456 451 456 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">JAZF1</italic>
###xml 469 480 469 480 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TSPAN8-LGR5</italic>
###xml 494 499 494 499 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">THADA</italic>
###xml 513 520 513 520 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ADAMTS9</italic>
###xml 534 547 534 547 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NOTCH2-ADAM30</italic>
###xml 579 592 579 592 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDC123-CAMK1D</italic>
###xml 951 952 951 952 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
We selected twenty-four SNPs from sixteen loci previously reported to be associated with type 2 diabetes at a genome-wide significance level, including PPARG (rs1801282), KCNJ11 (rs5219), WFS1 (rs10010131), TCF7L2 (rs7903146), CDKAL1 (rs10946398, rs7754840, rs9460546, rs7756992 and rs9465871), CDKN2A-CDKN2B (rs564398 and rs10811161), IDE-KIF11-HHEX (rs10509645, rs1111875 and rs10748582), IGF2BP2 (rs7651090), SLC30A8 (rs13266634), FTO (rs8050136), JAZF1 (rs864754), TSPAN8-LGR5 (rs7961581), THADA (rs7578597), ADAMTS9 (rs4607103), NOTCH2-ADAM30 (rs2641348 and rs10923931) and CDC123-CAMK1D (rs12779790). All the SNPs were genotyped using MassARRAY iPLEX system (MassARRAY Compact Analyzer, Sequenom, San Diego, CA). The genotyping underwent several quality control procedures. Two SNPs (rs12779790 and rs7903146) were excluded because of low call rate (<90%). One SNP (rs10923931) was excluded because of departure from Hardy-Weinberg equilibrium (P<0.01). The overall call rate for the remaining 21 SNPs was 96.8%. The concordant rate calculated based on 100 duplicates for each SNP was 99.6%.
###end p 22
###begin title 23
Statistical analyses
###end title 23
###begin p 24
###xml 69 70 67 68 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 355 359 353 357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007643-Purcell1">[19]</xref>
Allele frequencies between cases and controls were compared using chi2 test. The ORs with 95% confidence intervals (CIs) with respect to the risk alleles were presented. Genotype distributions between cases and controls were compared using logistic regression under a log additive model in PLINK after adjusting age, gender and BMI as confounding factors [19]. For genes with multiple SNPs genotyped, independent SNP effects were determined by logistic regression. Correction of multiple testing on allele association was performed using PLINK through 10,000 permutations that randomly permutated the case/control status independent of genotypes.
###end p 24
###begin p 25
###xml 396 397 396 397 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 417 421 417 421 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007643-Purcell1">[19]</xref>
For continuous trait analysis, quantitative trait association analyses were performed by linear regression after adjusting age, gender and BMI as confounding factors. Quantitative traits with skewed distribution were transformed to approximate univariate normality by natural logarithm. In order to adjust multiple comparison, 1,000 permutations were performed for each trait to assess empirical P values using PLINK [19]. Additive effect models were used for SNPs with MAFs >0.05. For SNPs with MAFs <0.05, dominant effect models were used because of the small numbers of homozygotes of rare alleles.
###end p 25
###begin p 26
The receiver operating characteristic (ROC) curves, a tool for displaying the discriminatory ability of a diagnostic marker in distinguishing between cases and controls, were used for evaluation of discriminative accuracy of age, gender, BMI and SNPs. The area under the ROC curve (AUC), the measurement of the ability of a marker to discriminate between the cases and controls, was calculated by using the logistic regression model. AUC comparisons between ROC curves were performed by MedCalc (version 10.3.2.0; Mariakerke, Belgium) using the method of Hanley and McNeil for ROC curve analyses.
###end p 26
###begin p 27
###xml 219 220 219 220 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
The statistic analyses were performed by using SAS for Windows (version 8.0; SAS Institute, Cary, NC) unless specified otherwise. As the genes analyzed in the current study were well replicated previously, a two-tailed P value of <0.05 was considered as statistically significant.
###end p 27
###begin title 28
Results
###end title 28
###begin p 29
###xml 157 164 157 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007643-t002">Table 2</xref>
###xml 170 183 170 183 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDKN2A-CDKN2B</italic>
###xml 301 302 301 302 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 339 344 339 344 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPARG</italic>
###xml 346 352 346 352 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KCNJ11</italic>
###xml 354 360 354 360 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDKAL1</italic>
###xml 362 376 362 376 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IDE-KIF11-HHEX</italic>
###xml 378 385 378 385 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IGF2BP2</italic>
###xml 390 397 390 397 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC30A8</italic>
###xml 490 491 490 491 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 521 527 521 527 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDKAL1</italic>
###xml 532 546 532 546 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IDE-KIF11-HHEX</italic>
###xml 665 671 665 671 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDKAL1</italic>
###xml 692 706 692 706 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IDE-KIF11-HHEX</italic>
###xml 924 930 924 930 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDKAL1</italic>
###xml 935 949 935 949 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IDE-KIF11-HHEX</italic>
###xml 1079 1085 1079 1085 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDKAL1</italic>
###xml 1087 1100 1087 1100 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDKN2A-CDKN2B</italic>
###xml 1102 1116 1102 1116 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IDE-KIF11-HHEX</italic>
###xml 1118 1125 1118 1125 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IGF2BP2</italic>
###xml 1130 1137 1130 1137 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC30A8</italic>
###xml 1208 1212 1208 1212 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WFS1</italic>
###xml 1228 1231 1228 1231 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FTO</italic>
###xml 1316 1317 1316 1317 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1371 1384 1371 1384 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDKN2A-CDKN2B</italic>
###xml 1408 1413 1408 1413 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">JAZF1</italic>
###xml 1415 1426 1415 1426 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TSPAN8-LGR5</italic>
###xml 1428 1433 1428 1433 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">THADA</italic>
###xml 1435 1442 1435 1442 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ADAMTS9</italic>
###xml 1444 1457 1444 1457 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NOTCH2-ADAM30</italic>
We first examined the potential effects of 21 SNPs successfully genotyped on type 2 diabetes susceptibility in our Chinese case-control samples. As shown in Table 2, the CDKN2A-CDKN2B rs10811661 showed strong association to type 2 diabetes, with an OR of 1.406 (95% CI 1.280-1.546) per risk allele T (P = 1.37E-12). In addition, SNPs from PPARG, KCNJ11, CDKAL1, IDE-KIF11-HHEX, IGF2BP2 and SLC30A8 were also moderately associated with type 2 diabetes, with ORs ranging from 1.114 to 1.282 (P<0.05). As multiple SNPs from CDKAL1 and IDE-KIF11-HHEX were genotyped, we analyzed the linkage disequilibrium extent among the SNPs from the same region. The five SNPs from CDKAL1 and three SNPs from IDE-KIF11-HHEX were in linkage disequilibrium, respectively. We then used logistic regression to determine the independent effects of these SNPs and found SNPs rs7756992 and rs10748582 conferred independent risks for the disease in CDKAL1 and IDE-KIF11-HHEX regions respectively (data not shown). However, after correction of multiple comparisons, only the association between SNPs from CDKAL1, CDKN2A-CDKN2B, IDE-KIF11-HHEX, IGF2BP2 and SLC30A8 and type 2 diabetes remained to be significant. And we also found the WFS1 rs10010131 and FTO rs8050136 showed trends towards association to type 2 diabetes in our samples (0.05<P<0.1). However, we failed to replicate the effects of CDKN2A-CDKN2B rs564398 and SNPs from JAZF1, TSPAN8-LGR5, THADA, ADAMTS9, NOTCH2-ADAM30, which were identified through meta-analysis of Caucasian GWAS.
###end p 29
###begin title 30
Association between SNPs from fourteen loci and type 2 diabetes in the Chinese.
###end title 30
###begin p 31
###xml 49 50 49 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 50 56 50 56 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">allele</sub>
###xml 64 65 64 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 146 147 146 147 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 147 155 147 155 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">genotype</sub>
###xml 163 164 163 164 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 312 313 312 313 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
The OR with 95% CI shown is for the risk allele. Pallele is the P value for comparison of the allele distribution between the cases and controls. Pgenotype is the P value for comparison of genotype distribution between the cases and controls after adjusting age, gender and BMI as confounding factors. Empirical P values were calculated through 10,000 permutations for the difference of allele distribution between cases and controls.
###end p 31
###begin p 32
###xml 104 111 104 111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007643-t003">Table 3</xref>
###xml 122 129 122 129 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC30A8</italic>
###xml 178 179 178 179 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 194 205 194 205 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TSPAN8-LGR5</italic>
###xml 249 250 249 250 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 378 379 378 379 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 470 473 458 461 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FTO</italic>
###xml 598 603 586 591 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">THADA</italic>
###xml 699 700 687 688 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
We then analyzed the effects of these SNPs on clinical measurements in the normal controls. As shown in Table 3, we found SLC30A8 rs13266634 was associated with fasting glucose (P = 0.0118) and TSPAN8-LGR5 rs7961581 was associated with 2-h glucose (P = 0.0404). For insulin levels, we found rs10811161, rs864754, rs7961581 and rs7578597 were associated with 2-h insulin levels (P = 0.0005approximately0.0257). For BMI, no significant association was detected, including FTO SNP rs8050136, which was previously reported to be an obesity gene in the Caucasians. However, only the association between THADA rs7578597 and 2-h insulin remained significant after correction of multiple testing (empirical P = 0.0090).
###end p 32
###begin title 33
Association of SNPs with clinical features related to glucose metabolism in the control subjects.
###end title 33
###begin p 34
###xml 231 232 231 232 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
Only SNPs showed nominal significant association to clinical features are shown in the table. AA represents the homozygotes of major allele. Aa represents the heterozygotes. aa represents the homozygotes of minor allele. Empirical P values were calculated through 1,000 permutations within each trait.
###end p 34
###begin p 35
###xml 446 447 446 447 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 597 602 597 602 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KCNQ1</italic>
###xml 617 621 617 621 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF2</italic>
###xml 803 808 803 808 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPARG</italic>
###xml 820 826 820 826 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KCNJ11</italic>
###xml 835 839 835 839 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WFS1</italic>
###xml 852 858 852 858 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDKAL1</italic>
###xml 870 883 870 883 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDKN2A-CDKN2B</italic>
###xml 896 910 896 910 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IDE-KIF11-HHEX</italic>
###xml 923 930 923 930 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IGF2BP2</italic>
###xml 942 949 942 949 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC30A8</italic>
###xml 962 965 962 965 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FTO</italic>
###xml 977 982 977 982 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KCNQ1</italic>
###xml 997 1001 997 1001 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF2</italic>
###xml 292 300 <span type="species:ncbi:9606">patients</span>
###xml 1156 1164 <span type="species:ncbi:9606">patients</span>
To further investigate if these susceptible loci affected the disease additively, we examined joint effects of risk alleles of SNPs from susceptible loci on type 2 diabetes. Here we analyzed if the individuals carrying more risk allele tended to have a higher risk for the disease and if the patients with more risk alleles tended to have an earlier diagnostic age. We also analyzed the diagnostic value of these SNPs. We only selected SNPs with P values less than 0.1. For loci with multiple SNPs genotyped, the SNP showed strongest association from each locus was selected. Two additional SNPs, KCNQ1 rs2237892 and TCF2 rs4430796, which were previously genotyped and showed significant association to type 2 diabetes in our samples, were also included into the combined analysis. Totally eleven SNPs (PPARG rs1801282, KCNJ11 rs5219, WFS1 rs10010131, CDKAL1 rs7756992, CDKN2A-CDKN2B rs10811161, IDE-KIF11-HHEX rs10748582, IGF2BP2 rs7651090, SLC30A8 rs13266634, FTO rs8050136, KCNQ1 rs2237892 and TCF2 rs4430796) were selected into the analysis. And we only included individuals with the genotypes of all these eleven SNPs available (1,359 type 2 diabetes patients and 1,532 normoglycaemic controls) into the analysis.
###end p 35
###begin p 36
###xml 103 110 103 110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007643-g001">Fig. 1A</xref>
###xml 113 114 113 114 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 114 119 114 119 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trend</sub>
###xml 441 442 441 442 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 726 727 721 722 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 739 746 734 741 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007643-g001">Fig. 1C</xref>
###xml 894 895 884 885 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1331 1332 1321 1322 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1344 1351 1334 1341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007643-g001">Fig. 1D</xref>
###xml 1434 1440 1424 1430 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
###xml 1445 1458 1435 1448 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDC123-CAMK1D</italic>
###xml 43 51 <span type="species:ncbi:9606">patients</span>
###xml 576 584 <span type="species:ncbi:9606">patients</span>
###xml 590 598 <span type="species:ncbi:9606">patients</span>
We found the proportion of type 2 diabetes patients increased in the subgroups with more risk alleles (Fig. 1A) (Ptrend = 1.34E-30). When treating the individuals carrying less than 9 risk alleles (6.6% of the study population) as reference group, the subgroups carrying more risk alleles had a significantly higher risk for type 2 diabetes, with each additional risk allele increased type 2 diabetes risk by 1.265-fold (95%CI: 1.214-1.318, P = 2.66E-29). Moreover, we found the number of risk alleles was significantly associated with age-at-diagnosis in the type 2 diabetes patients. The patients carrying more risk alleles tended to have a younger diagnostic age (beta = -0.60+/-0.17 years per each additional risk allele, P = 0.0006) (Fig. 1C). And this association remained significant after further adjusting sex and BMI as confounding factors (beta = -0.65+/-0.18 years per risk allele, P = 0.0002). We also evaluated the predictive value of these genetic variants in the Chinese population. In our samples, the AUC for clinical characteristic including age, sex and BMI was 0.614 (95%CI 0.595-0.632) while the AUC for the number of risk alleles was 0.621 (95%CI 0.604-0.639). But when adding the number of risk alleles to the regression model of age, sex and BMI, the AUC increased marginally to 0.668 (95%CI 0.650-0.685) (P = 0.0002) (Fig. 1D). We also analyzed the joint effect of SNPs from all sixteen loci (only excluding TCF7L2 and CDC123-CAMK1D that failed genotyping) and got similar results (data not shown).
###end p 36
###begin title 37
The joint effect of risk alleles on type 2 diabetes susceptibility.
###end title 37
###begin p 38
###xml 254 255 254 255 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 255 260 255 260 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trend</sub>
###xml 412 413 412 413 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 574 575 572 573 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 65 73 <span type="species:ncbi:9606">patients</span>
###xml 194 202 <span type="species:ncbi:9606">patients</span>
A. Distribution of number of risk alleles in the type 2 diabetes patients and normoglycaemic controls. Black bar = normoglycaemic, white bar = type 2 diabetes. The proportion of type 2 diabetes patients increased in the subgroups with more risk alleles (Ptrend = 1.34E-30). B. The risk for type 2 diabetes increased according to the increase of number of risk alleles, (OR 1.265 per each additional risk allele, P = 2.66E-29). C. The age-at-diagnosis decreased according to the increase of number of risk alleles carried (-0.60+/-0.17 years per each additional risk allele, P = 0.0006). D. ROC curves for models containing number of risk alleles (AUC = 0.621), clinical characteristics including age, sex and BMI (AUC = 0.614) and both (AUC = 0.668).
###end p 38
###begin title 39
Discussion
###end title 39
###begin p 40
###xml 57 62 57 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPARG</italic>
###xml 64 70 64 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KCNJ11</italic>
###xml 72 78 72 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDKAL1</italic>
###xml 80 93 80 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDKN2A-CDKN2B</italic>
###xml 95 109 95 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IDE-KIF11-HHEX</italic>
###xml 111 118 111 118 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IGF2BP2</italic>
###xml 123 130 123 130 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC30A8</italic>
###xml 224 227 224 227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007643-Zeggini1">[2]</xref>
###xml 229 232 229 232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007643-Saxena1">[3]</xref>
###xml 234 237 234 237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007643-Scott1">[4]</xref>
###xml 239 242 239 242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007643-Sladek1">[5]</xref>
###xml 276 280 276 280 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WFS1</italic>
###xml 285 288 285 288 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FTO</italic>
###xml 725 729 725 729 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007643-Franks1">[20]</xref>
###xml 731 735 731 735 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007643-Frayling1">[21]</xref>
###xml 855 858 855 858 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FTO</italic>
###xml 956 959 956 959 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FTO</italic>
###xml 1235 1238 1235 1238 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007643-Zeggini2">[6]</xref>
###xml 1585 1588 1585 1588 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007643-Zeggini2">[6]</xref>
In this study, we confirmed the effects of variations in PPARG, KCNJ11, CDKAL1, CDKN2A-CDKN2B, IDE-KIF11-HHEX, IGF2BP2 and SLC30A8 on type 2 diabetes. The ORs of the risk alleles were similar to those reported in Caucasians [2], [3], [4], [5]. Our finding also supported that WFS1 and FTO might participate in the pathogenesis of type 2 diabetes, although the effects we detected on rs10010131 and rs8050136 were not statistically significant. The non-significance could be explained by the different genetic background between Caucasian and Asian populations. Compared with Caucasians, the MAFs of these two variants were much rarer in the Chinese populations (0.05 vs. 0.40 for rs10010131 and 0.125 vs. 0.45 for rs8050136) [20], [21], which reduced the statistical power of our samples dramatically. It should also be noted that the non-significance of FTO SNP may be partly explained by the similar BMI between the cases and controls in our samples, as FTO variant increases type 2 diabetes risk mainly through increasing BMI. However, we failed to replicate the effects of SNPs reported by DIAGRAM study. As these loci were identified by a meta-analysis in over 10,000 individuals and replicated in over 50,000 independent samples [6], the effect sizes of these genes were relatively low compared with other loci. Moreover, several SNPs (rs7578597spor and rs2641348) were rare variants in the Asian populations. Therefore, we did not have enough power to replicate these associations in our samples. But the risk alleles of all the SNPs were the same as reported in the Caucasians [6].
###end p 40
###begin p 41
###xml 53 58 53 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">THADA</italic>
###xml 132 137 132 137 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">THADA</italic>
###xml 200 204 200 204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007643-Drieschner1">[22]</xref>
###xml 218 223 218 223 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">THADA</italic>
###xml 521 525 521 525 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007643-Grarup1">[23]</xref>
###xml 527 531 527 531 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007643-Grarup2">[24]</xref>
###xml 605 609 605 609 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007643-Wu1">[12]</xref>
###xml 634 647 634 647 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDKN2A-CDKN2B</italic>
###xml 649 656 649 656 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IGF2BP2</italic>
###xml 661 668 661 668 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC30A8</italic>
###xml 837 841 837 841 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007643-Ng1">[11]</xref>
We also found rs7578597, a non-synonymous variant of THADA, was associated with 2-h insulin levels in the controls. Evidence showed THADA might be involved in the death receptor pathway and apoptosis [22]. But whether THADA has similar effect on beta cell and how it participates in the pathogenesis of type 2 diabetes and insulin secretion is still unknown. Several study suggested the predominant effect of the genetic contribution to type 2 diabetes was mediated through defect in insulin secretion rather than action [23], [24]. But none of the SNPs we analyzed showed association to HOMA-B. Wu et al [12] reported that SNPs from CDKN2A-CDKN2B, IGF2BP2 and SLC30A8 showed association to beta cell function in the Chinese; however, negative finding was also reported in the current study and another study with equivalent sample size [11]. Thus the effects of these variants on clinical characteristics in the Chinese still need to be investigated in cohorts with more samples.
###end p 41
###begin p 42
###xml 325 329 325 329 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007643-Lango1">[25]</xref>
###xml 331 335 331 335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007643-vanHoek1">[26]</xref>
###xml 354 362 <span type="species:ncbi:9606">patients</span>
The joint effect analysis showed that these susceptible loci worked in an additive way and the subgroup of populations with more risk alleles tended to have a higher risk for the disease. However, the predictive value of these risk variants was limited in our samples. This was similar to the previous findings in Caucasians [25], [26]. But we found the patients with more risk alleles tended to have an earlier onset age of diabetes. Whether individuals with extremely more risk alleles could benefit from genetic testing and whether lifestyle intervention could reduce the risk in this subgroup of individuals remained to be investigated.
###end p 42
###begin p 43
Although the findings presented are interesting, they should be viewed with caution. First, we cannot fully exclude the possibility the population stratification exists in our samples. Although both the cases and controls were recruited from the same city, recent large-scale migration from other regions of the country into Shanghai may lead to some degree of stratification. However, according to the records of our standard questionnaires, all of our samples lived in Eastern China more than three generations, thus the effect of population stratification may be limited in our samples. Second, as multiple traits were analyzed in the current study, the possibility still exists that our findings were false positive, especially for the continuous traits which lack replication in other independent samples.
###end p 43
###begin p 44
###xml 52 57 52 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPARG</italic>
###xml 59 65 59 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KCNJ11</italic>
###xml 67 73 67 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDKAL1</italic>
###xml 75 88 75 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDKN2A-CDKN2B</italic>
###xml 90 104 90 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IDE-KIF11-HHEX</italic>
###xml 106 113 106 113 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IGF2BP2</italic>
###xml 115 122 115 122 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC30A8</italic>
In conclusion, we confirmed the association between PPARG, KCNJ11, CDKAL1, CDKN2A-CDKN2B, IDE-KIF11-HHEX, IGF2BP2, SLC30A8 variants and type 2 diabetes. These risk loci contributed to type 2 diabetes additively. Further studies in Asian cohorts with prospective data and information on environmental factors are needed to better elucidate the effects of these genetic variants on diabetes risk and their interaction with environment.
###end p 44
###begin p 45
###xml 17 29 <span type="species:ncbi:9606">participants</span>
We thank all the participants of this research. We particularly thank Huijuan Lu, Xiaosi Li, Jing Xu, Junling Tang, Xiaoping Pan and Jie Li for their outstanding technical assistance. We thank all nursing and medical staff at Shanghai Clinical Center for Diabetes for their dedication in this study.
###end p 45
###begin title 46
References
###end title 46
###begin article-title 47
The genetics of type 2 diabetes.
###end article-title 47
###begin article-title 48
Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes.
###end article-title 48
###begin article-title 49
Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels.
###end article-title 49
###begin article-title 50
A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants.
###end article-title 50
###begin article-title 51
A genome-wide association study identifies novel risk loci for type 2 diabetes.
###end article-title 51
###begin article-title 52
Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes.
###end article-title 52
###begin article-title 53
SNPs in KCNQ1 are associated with susceptibility to type 2 diabetes in East Asian and European populations.
###end article-title 53
###begin article-title 54
Variants in KCNQ1 are associated with susceptibility to type 2 diabetes mellitus.
###end article-title 54
###begin article-title 55
Evaluation of common variants in the six known maturity-onset diabetes of the young (MODY) genes for association with type 2 diabetes.
###end article-title 55
###begin article-title 56
Candidate gene studies reveal that the WFS1 gene joins the expanding list of novel type 2 diabetes genes.
###end article-title 56
###begin article-title 57
Implication of genetic variants near TCF7L2, SLC30A8, HHEX, CDKAL1, CDKN2A/B, IGF2BP2, and FTO in type 2 diabetes and obesity in 6,719 Asians.
###end article-title 57
###begin article-title 58
Common variants in CDKAL1, CDKN2A/B, IGF2BP2, SLC30A8, and HHEX/IDE genes are associated with type 2 diabetes and impaired fasting glucose in a Chinese Han population.
###end article-title 58
###begin article-title 59
Replication of genome-wide association studies of type 2 diabetes susceptibility in Japan.
###end article-title 59
###begin article-title 60
Variations in KCNQ1 are associated with type 2 diabetes and beta cell function in a Chinese population.
###end article-title 60
###begin article-title 61
Common Variants of Hepatocyte Nuclear Factor 1B are Associated with Type 2 Diabetes in a Chinese Population.
###end article-title 61
###begin article-title 62
Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation.
###end article-title 62
###begin article-title 63
Epidemiological characteristics of diabetes mellitus and impaired glucose regulation in a Chinese adult population: the Shanghai Diabetes Studies, a cross-sectional 3-year follow-up study in Shanghai urban communities.
###end article-title 63
###begin article-title 64
###xml 130 133 <span type="species:ncbi:9606">man</span>
Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man.
###end article-title 64
###begin article-title 65
PLINK: a tool set for whole-genome association and population-based linkage analyses.
###end article-title 65
###begin article-title 66
Replication of the association between variants in WFS1 and risk of type 2 diabetes in European populations.
###end article-title 66
###begin article-title 67
A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity.
###end article-title 67
###begin article-title 68
A domain of the thyroid adenoma associated gene (THADA) conserved in vertebrates becomes destroyed by chromosomal rearrangements observed in thyroid adenomas.
###end article-title 68
###begin article-title 69
Studies of association of variants near the HHEX, CDKN2A/B, and IGF2BP2 genes with type 2 diabetes and impaired insulin release in 10,705 Danish subjects: validation and extension of genome-wide association studies.
###end article-title 69
###begin article-title 70
Association testing of novel type 2 diabetes risk alleles in the JAZF1, CDC123/CAMK1D, TSPAN8, THADA, ADAMTS9, and NOTCH2 loci with insulin release, insulin sensitivity, and obesity in a population-based sample of 4,516 glucose-tolerant middle-aged Danes.
###end article-title 70
###begin article-title 71
Assessing the combined impact of 18 common genetic variants of modest effect sizes on type 2 diabetes risk.
###end article-title 71
###begin article-title 72
Predicting type 2 diabetes based on polymorphisms from genome-wide association studies: a population-based study.
###end article-title 72
###begin p 73
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 73
###begin p 74
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
###xml 323 329 <span type="species:ncbi:9606">Person</span>
Funding: This work was supported by grants from the Project of National Natural Science Foundation of China (30800617 and 30630061), National 973 Program (2006CB503901), National 863 Program (2006AA02A409), Shanghai Key Laboratory of Diabetes Mellitus (08DZ2230200), Shanghai Rising-Star Program (09QA1404400), One Hundred Person Fund from Shanghai Jiao Tong University School of Medicine and a grant from European Foundation for the Study of Diabetes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 74

